Antiviral Flashcards

1
Q

What are the steps to viral replication?

A
  1. attachment/entry
  2. uncoating
  3. early protein synthesis
  4. DNA/RNA replication
  5. Late protein synthesis
  6. Assembly/maturation
  7. Release
  • antiviral drugs will target these
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Oseltamivir

A

Use

  • prevent/treat early influenza A & B
  • H1N1 = subtype of influenza A

Mechanism

  • neuraminidase inhibitor
  • sialic acid analog
    • cleaves sialic acid of infected host cell -> release virus
  • prodrug to be metabolized by liver and GI tract

Adverse Effects

  • nausea, GI discomfort

Resistance

  • mutation in neuraminidase, however if there is a mutation virus is usually less virulent
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Amantadine

A

Use:

  • treat early influenza A
  • NOT H1N1

Mechanism:

  • inhibit proton ion channel M2 –> inhibit virus binding to endosome –> inhibits coating of virus.
  • distributed thoughou body, CNS, UNCHANGED BY KIDNEY

Adverse Effects

  • GI disturbances
  • CNS disturbance
  • renal damage w/ renal insufficiency

Resistance

  • mutation to M2
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

acyclovir

A

Use:

  • herpes infection

Mechanism

  • guanosine analogy –> activcated by thymidine kinase –> infected cells susceptible tri-phosphate acyclovir that compete w/ dGTP during DNA synthesis = DNA termination
  • oral, IV or topical formulation distributed though body, CNS

Adverse Effects:

  • nausea, vomitting, diarrhea, headache, renal damage

Resistance:

  • altered or deficient thymidine kinase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

zidovudine (AZT)

A

Use:

  • HIV

Mechanism

  • nucleoside reverse transcriptase inhibitor
  • thymidine analogue –> phosphorylated by mammalian kinase viral reverse transcriptase –> compete with dTTP during DNA synthesis –> DNA termination
  • well distributed, CNS, metabolized in liver (glucoronidation)

Adverse Effects:

  • Bone marrow
    • anemia, netropenia
  • Heaptotoxicity
  • drug interactions
    • drugs competing with glucoronidation (acetaminophen, beznodiaszepines)

Resistance

  • reverse transcriptase mutation, inefficient kinase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

nevirapine

A

Use:

  • treatment of HIV

Mechanism:

  • Non-nucleoside reverse transcriptase inhibitor (NNRTIs)
  • binds to non-catalytic site inhibiting reverse transcriptase
  • well absored, CNS, fetus, tit milk, metabolized in liver –> glucoronidation

Adverse effects:

  • rash, psychiatric effects
  • heptatotoxicity
  • inc CYP3A4 –> inc metabolism of other drugs ex itselff, AZOLES, protease inhibitors

Resistance:

  • reverse transcriptase mutation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

ritonavir

A

Use

  • treat HIV

Mechanism:

  • Protease inhibitor
  • inhibit HIV aspartyl protease
  • inhibits CYP450, given as enhance of other PIs
  • give with choco MILK! or nutritional suppplement cause unpalatable!
  • metabolized by CYP3A4

Adverse effects:

  • nausea, vomiting, diarrhea, numbness, elevated liver enzymes
  • high bl glucose and lipid levels

Resistance

  • mutation in protease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

maraviroc

A

use:

  • treat HIV

Mechanism:

  • viral entry inhibitor
  • CCR5 reveptor antagonist blocks binding of viral gp120 to CCR5 –> prevent viral entry
  • dec viral load in patients

Adverse Effects

  • hepatotoxicity and cardriovascular
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

raltegravir

A

Use:

  • treat HIV

Mechanism

  • Integrase inhibitor
  • dec transfer of viral DNA into host genome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

HAART

A

what is it

  • highly active antiretroviral therapy
  • First line treatment = combo of 3 antiviral drugs

HAART = 2 NRTIs + NNRTI or PI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly